Genenta Science SPA (Genenta Science SPA) Price-to-Operating-Cash-Flow : (As of May. 25, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA Price-to-Operating-Cash-Flow?

As of today (2024-05-25), Genenta Science SPA's share price is $3.30. Genenta Science SPA's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.67. Hence, Genenta Science SPA's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Genenta Science SPA's Price-to-Operating-Cash-Flow or its related term are showing as below:

GNTA's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.275
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Genenta Science SPA's Cash Flow from Operations per share for the six months ended in Dec. 2023 was $-0.22. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.67.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -14.60% per year.

During the past 5 years, Genenta Science SPA's highest 3-Year average Operating Cash Flow per Share Growth Rate was -14.60% per year. The lowest was -34.00% per year. And the median was -24.30% per year.

Genenta Science SPA Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Genenta Science SPA's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA Price-to-Operating-Cash-Flow Chart

Genenta Science SPA Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Genenta Science SPA Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Genenta Science SPA's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Genenta Science SPA's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genenta Science SPA's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genenta Science SPA's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Genenta Science SPA's Price-to-Operating-Cash-Flow falls into.

Genenta Science SPA Price-to-Operating-Cash-Flow Calculation

Genenta Science SPA's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	3.30	/	-0.668
	=

Genenta Science SPA's Share Price of today is $3.30.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genenta Science SPA's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.67.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Genenta Science SPA Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Genenta Science SPA (Genenta Science SPA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

K5F:Germany

Address

Via Olgettina No. 58, Milan, ITA, 20132

Website

https://www.genenta.com

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.